1. Home
  2. ZVRA vs BOC Comparison

ZVRA vs BOC Comparison

Compare ZVRA & BOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZVRA
  • BOC
  • Stock Information
  • Founded
  • ZVRA 2006
  • BOC 2009
  • Country
  • ZVRA United States
  • BOC United States
  • Employees
  • ZVRA N/A
  • BOC N/A
  • Industry
  • ZVRA Biotechnology: Pharmaceutical Preparations
  • BOC
  • Sector
  • ZVRA Health Care
  • BOC
  • Exchange
  • ZVRA Nasdaq
  • BOC Nasdaq
  • Market Cap
  • ZVRA 467.6M
  • BOC 413.9M
  • IPO Year
  • ZVRA 2015
  • BOC 2017
  • Fundamental
  • Price
  • ZVRA $10.18
  • BOC $12.72
  • Analyst Decision
  • ZVRA Strong Buy
  • BOC Strong Buy
  • Analyst Count
  • ZVRA 7
  • BOC 1
  • Target Price
  • ZVRA $22.57
  • BOC $25.00
  • AVG Volume (30 Days)
  • ZVRA 1.8M
  • BOC 176.3K
  • Earning Date
  • ZVRA 11-05-2025
  • BOC 11-13-2025
  • Dividend Yield
  • ZVRA N/A
  • BOC N/A
  • EPS Growth
  • ZVRA N/A
  • BOC N/A
  • EPS
  • ZVRA N/A
  • BOC 0.02
  • Revenue
  • ZVRA $62,020,000.00
  • BOC $111,568,551.00
  • Revenue This Year
  • ZVRA $336.43
  • BOC $7.79
  • Revenue Next Year
  • ZVRA $54.26
  • BOC $3.80
  • P/E Ratio
  • ZVRA N/A
  • BOC $613.84
  • Revenue Growth
  • ZVRA 161.81
  • BOC 9.53
  • 52 Week Low
  • ZVRA $6.19
  • BOC $12.27
  • 52 Week High
  • ZVRA $13.16
  • BOC $16.20
  • Technical
  • Relative Strength Index (RSI)
  • ZVRA 47.76
  • BOC 35.17
  • Support Level
  • ZVRA $10.03
  • BOC $13.69
  • Resistance Level
  • ZVRA $11.23
  • BOC $13.97
  • Average True Range (ATR)
  • ZVRA 0.56
  • BOC 0.28
  • MACD
  • ZVRA -0.14
  • BOC -0.14
  • Stochastic Oscillator
  • ZVRA 7.41
  • BOC 3.51

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

About BOC Boston Omaha Corporation

Boston Omaha Corp is a United States based company which invests in real estate. Its operations include its ownership of multiple billboards in Florida, Georgia, Wisconsin, and Alabama and equity method investments in several real estate companies. The company operates four separate lines of business, outdoor billboard advertising, the broadband services industry, the insurance industry, and the asset management industry. Company generate revenue from outdoor advertising through the leasing of advertising space on billboards. It also generate revenue from commissions on surety bond sales and account for commissions and principally from internet services and is recognized on a straight-line basis over the term of the contract in the period the services are rendered.

Share on Social Networks: